Prof. Yadid has a broad scientific background in both pharmacology and neuroscience, with specific training and expertise in key research areas including drug addiction and psychiatric diseases. His research group focuses on developing pharmacological and non-pharmacological treatment modalities for psychiatric diseases – specifically, drug addiction, depression, and post-traumatic stress disorder (PTSD), using behavioral models in combination with neurochemical, molecular and computational methods and nanotechnology, in a bi-directional approach. Prof. Yadid's lab has discovered several major findings in these areas. Moreover, as a neuropharmacologist, Yadid promotes new therapeutic strategies and R&D of new potential drugs, in collaboration with pharmaceutical companies.